These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34813249)

  • 1. [Obesity-fatty liver: the role of the pediatrician].
    Ciocca M; Álvarez F
    Arch Argent Pediatr; 2021 Dec; 119(6):427-430. PubMed ID: 34813249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in understanding and managing pediatric nonalcoholic fatty liver disease.
    Vittorio J; Lavine JE
    F1000Res; 2020; 9():. PubMed ID: 32509277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Younossi ZM; Corey KE; Lim JK
    Gastroenterology; 2021 Feb; 160(3):912-918. PubMed ID: 33307021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approach to Pediatric Obesity and Nonalcoholic Fatty Liver Disease.
    Ascher Bartlett JM; Mittal N
    Pediatr Ann; 2021 Nov; 50(11):e474-e477. PubMed ID: 34757877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease: lifestyle and quality of life.
    Vachliotis I; Goulas A; Papaioannidou P; Polyzos SA
    Hormones (Athens); 2022 Mar; 21(1):41-49. PubMed ID: 34854066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease: a systematic review.
    Rinella ME
    JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From "two hit theory" to "multiple hit model".
    Fang YL; Chen H; Wang CL; Liang L
    World J Gastroenterol; 2018 Jul; 24(27):2974-2983. PubMed ID: 30038464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.
    Crespo M; Lappe S; Feldstein AE; Alkhouri N
    Metabolism; 2016 Aug; 65(8):1161-71. PubMed ID: 26961580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic fatty liver disease: a challenge for pediatricians.
    Nobili V; Alkhouri N; Alisi A; Della Corte C; Fitzpatrick E; Raponi M; Dhawan A
    JAMA Pediatr; 2015 Feb; 169(2):170-6. PubMed ID: 25506780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.
    Lin CH; Kohli R
    Curr Gastroenterol Rep; 2020 Aug; 22(10):52. PubMed ID: 32814993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis.
    Hohenester S; Christiansen S; Nagel J; Wimmer R; Artmann R; Denk G; Bischoff M; Bischoff G; Rust C
    Am J Physiol Gastrointest Liver Physiol; 2018 Sep; 315(3):G329-G338. PubMed ID: 29878845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pediatric Non-alcoholic Fatty Liver Disease.
    Uppal V; Mansoor S; Furuya KN
    Curr Gastroenterol Rep; 2016 May; 18(5):24. PubMed ID: 27086005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and diagnosis of fatty liver disease.
    Schneier AT; Citti CC; Dieterich DT
    Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):671-83. PubMed ID: 25716275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis.
    Africa JA; Behling CA; Brunt EM; Zhang N; Luo Y; Wells A; Hou J; Belt PH; Kohil R; Lavine JE; Molleston JP; Newton KP; Whitington PF; Schwimmer JB;
    Clin Gastroenterol Hepatol; 2018 Mar; 16(3):438-446.e1. PubMed ID: 28286193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic Fatty Liver Disease: Common Questions and Answers on Diagnosis and Management.
    Westfall E; Jeske R; Bader AR
    Am Fam Physician; 2020 Nov; 102(10):603-612. PubMed ID: 33179890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease.
    Makri E; Goulas A; Polyzos SA
    Arch Med Res; 2021 Jan; 52(1):25-37. PubMed ID: 33334622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
    Carr RM; Oranu A; Khungar V
    Gastroenterol Clin North Am; 2016 Dec; 45(4):639-652. PubMed ID: 27837778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.
    Pattison RJ; Esteban JP; Sempokuya T; Kewcharoen J; Kalathil S; Kuwada SK
    Hawaii J Health Soc Welf; 2020 Jun; 79(6):180-186. PubMed ID: 32524096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.